An Antigen‐Capturing Nanoparticle Harnesses the Protein Corona to Enhance Antigenic Immunogenicity and Clonal Diversity against Cancer
Advanced Materials · 2026
DOI: 10.1002/adma.202519037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Shixuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Jiang Su Key Laboratory of Drug Design and Optimization, State Key Laboratory of Natural Medicines, China Pharmaceutical…. Hauptthemen laut MEDLINE: Nanoparticles, Antigens, Neoplasm, Protein Corona, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key R&D Program of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Neoantigen vaccines are often limited by inter/intra‐patient heterogenicity as well as labor‐intensive production. Balancing personalization and universality remains challenging. While the protein corona that forms on nanoparticles has long been viewed as a detrimental factor, it can be strategically harnessed to align with an individual's unique antigenic landscape. Here, we introduce a “BET‐dependent Antigen‐capturing ImmunoTransmitter (BAIT)” as an in situ nanovaccine to expand the antigenic breadth and clonal diversity of antitumor immunity. By synthesizing a series of metal–organic frameworks with tunable defect concentrations and pore densities, we find that the antigen‐capturing capacity is positively correlated with the BET surface area. BAIT keeps “Off” in vivo but turns “On” in the acidic tumor microenvironment, where it spontaneously creates an active antigen corona for uptake and cross‐presentation by type‐I conventional dendritic cells (cDC1s), increasing both availability and immunogenicity of endogenous antigens. Consequently, BAIT elicits broad‐spectrum T cell responses against tumor heterogenicity. Depletion of cDC1s in Batf3 −/− mice abolishes its effect. BAIT further synergizes with treatments that increase local tumor antigen load, such as chemotherapy and radiotherapy, to eradicate cold tumors and prevent recurrence. Its feasibility is validated in human patient samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Jiang Su Key Laboratory of Drug Design and Optimization, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
- State Key Laboratory of Green Chemical Synthesis and Conversion, College of Chemical Engineering, Zhejiang University of Technology, Hangzhou, China.
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Ti…
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
ORCID-Profile: Suxin Li
Förderung
- National Key R&D Program of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Project of the State Key Laboratory of Natural Medicines
- Druggability Evaluation and Systematic Translational Medicine of Tianjin Medical University Cancer Institute & Hospital
- National Key Research and Development Program of China
Zitieren
APA
Li, S., Han, H., Xia, Y., Wang, K., Wang, X., Yu, W., Wang, Q., Hu, Y., Xu, J., Yang, X., She, Y., Zhang, Q., Wang, J., & Li, S. (2026). An Antigen‐Capturing Nanoparticle Harnesses the Protein Corona to Enhance Antigenic Immunogenicity and Clonal Diversity against Cancer. Advanced Materials. https://doi.org/10.1002/adma.202519037
Vancouver
Li S, Han H, Xia Y, Wang K, Wang X, Yu W, et al. An Antigen‐Capturing Nanoparticle Harnesses the Protein Corona to Enhance Antigenic Immunogenicity and Clonal Diversity against Cancer. Advanced Materials. 2026. doi:10.1002/adma.202519037
BibTeX
@article{Li2026,
author = {Li, Shixuan and Han, Huiyun and Xia, Yanming and Wang, Keke and Wang, Xiaohu and Yu, Wenwen and Wang, Qiran and Hu, Yuhan and Xu, Jieli and Yang, Xuqi and She, Yuanbin and Zhang, Qiang and Wang, Jian and Li, Suxin},
title = {An Antigen‐Capturing Nanoparticle Harnesses the Protein Corona to Enhance Antigenic Immunogenicity and Clonal Diversity against Cancer},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202519037}
}
EUVIMED